Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.
Read More »Improve Cardiovascular Outcomes with DPP4 Inhibitors
DPP4 inhibitors may restore the normal functioning of vascular endothelium in patients who require insulin treatment.
Read More »Preventing Diabetes with Antihypertensives
Researchers showed that elevated blood pressure is a modifiable risk factor for new-onset type 2 diabetes.
Read More »New Screening Tool to Prevent Mortality from Complications of Foot Ulcers
Risk factors associated with diabetic foot ulcers (DFU) are easily found in medical records, giving clinicians a tool for early detection.
Read More »Why Fractures and Falls in Type 2 Diabetes?
A prospective study found an increased risk for fractures and falls among older women with type 2 diabetes.
Read More »Efpeglenatide Has Cardiovascular and Renal Benefit Outcomes in Type 2 Diabetes
Efpeglenatide has proven to significantly reduce several risk factors for cardiovascular and kidney disease.
Read More »Linagliptin and Glimepiride
According to current research, linagliptin had a significantly lower risk of hypoglycemia and adverse events in geriatric patients with type 2 diabetes.
Read More »The Diverse Patterns of HbA1c from Childhood to Adolescence
Identifying high-risk patients with unstable HbA1c levels from childhood to adolescence can have significant outcomes.
Read More »Targeting Lower A1C Levels May Reduce Mortality in the Elderly
Evidence suggests A1C levels higher than 7% increase the risks of cardiovascular events in patients 70 years or older with T2D.
Read More »Incidence of Proliferative Diabetic Retinopathy at 5 years After T2D
How do factors such as insulin use and blood glucose control impact the overall risk of developing diabetic complications 5 years after type 2 diagnosis?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.